442 related articles for article (PubMed ID: 22030546)
1. Stroke research at a crossroad: asking the brain for directions.
Iadecola C; Anrather J
Nat Neurosci; 2011 Oct; 14(11):1363-8. PubMed ID: 22030546
[TBL] [Abstract][Full Text] [Related]
2. Focal cerebral ischemia and neurovascular protection: a bench-to-bedside update.
Tasker RC; Duncan ED
Curr Opin Pediatr; 2015 Dec; 27(6):694-9. PubMed ID: 26418322
[TBL] [Abstract][Full Text] [Related]
3. Targeting vascular inflammation in ischemic stroke: Recent developments on novel immunomodulatory approaches.
Shekhar S; Cunningham MW; Pabbidi MR; Wang S; Booz GW; Fan F
Eur J Pharmacol; 2018 Aug; 833():531-544. PubMed ID: 29935175
[TBL] [Abstract][Full Text] [Related]
4. Injury and repair mechanisms in ischemic stroke: considerations for the development of novel neurotherapeutics.
Candelario-Jalil E
Curr Opin Investig Drugs; 2009 Jul; 10(7):644-54. PubMed ID: 19579170
[TBL] [Abstract][Full Text] [Related]
5. SB 234551 selective ET(A) receptor antagonism: perfusion/diffusion MRI used to define treatable stroke model, time to treatment and mechanism of protection.
Legos JJ; Lenhard SC; Haimbach RE; Schaeffer TR; Bentley RG; McVey MJ; Chandra S; Irving EA; Andrew A Parsons ; Barone FC
Exp Neurol; 2008 Jul; 212(1):53-62. PubMed ID: 18462720
[TBL] [Abstract][Full Text] [Related]
6. Opioids modulate post-ischemic progression in a rat model of stroke.
Kao TK; Ou YC; Liao SL; Chen WY; Wang CC; Chen SY; Chiang AN; Chen CJ
Neurochem Int; 2008 May; 52(6):1256-65. PubMed ID: 18294735
[TBL] [Abstract][Full Text] [Related]
7. Neuroprotection in the Treatment of Acute Ischemic Stroke.
Patel RAG; McMullen PW
Prog Cardiovasc Dis; 2017; 59(6):542-548. PubMed ID: 28465001
[TBL] [Abstract][Full Text] [Related]
8. Neuroprotection via AT
Bennion DM; Steckelings UM; Sumners C
Clin Sci (Lond); 2018 May; 132(10):1055-1067. PubMed ID: 29802210
[TBL] [Abstract][Full Text] [Related]
9. Deciphering the neuroprotective mechanisms of Bu-yang Huan-wu decoction by an integrative neurofunctional and genomic approach in ischemic stroke mice.
Wang HW; Liou KT; Wang YH; Lu CK; Lin YL; Lee IJ; Huang ST; Tsai YH; Cheng YC; Lin HJ; Shen YC
J Ethnopharmacol; 2011 Oct; 138(1):22-33. PubMed ID: 21784143
[TBL] [Abstract][Full Text] [Related]
10. Chloral Hydrate Preconditioning Protects Against Ischemic Stroke via Upregulating Annexin A1.
Liu JH; Feng D; Zhang YF; Shang Y; Wu Y; Li XF; Pei L
CNS Neurosci Ther; 2015 Sep; 21(9):718-26. PubMed ID: 26205642
[TBL] [Abstract][Full Text] [Related]
11. Disrupted Ionic Homeostasis in Ischemic Stroke and New Therapeutic Targets.
Hu HJ; Song M
J Stroke Cerebrovasc Dis; 2017 Dec; 26(12):2706-2719. PubMed ID: 29054733
[TBL] [Abstract][Full Text] [Related]
12. Thrombolysis and neuroprotection in cerebral ischemia.
Gutiérrez M; Díez Tejedor E; Alonso de Leciñana M; Fuentes B; Carceller F; Roda JM
Cerebrovasc Dis; 2006; 21 Suppl 2():118-26. PubMed ID: 16651822
[TBL] [Abstract][Full Text] [Related]
13. Neuroprotective Strategies for Ischemic Stroke-Future Perspectives.
Haupt M; Gerner ST; Bähr M; Doeppner TR
Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901765
[TBL] [Abstract][Full Text] [Related]
14. Physical exercise training and neurovascular unit in ischemic stroke.
Wang X; Zhang M; Feng R; Li WB; Ren SQ; Zhang J; Zhang F
Neuroscience; 2014 Jun; 271():99-107. PubMed ID: 24780769
[TBL] [Abstract][Full Text] [Related]
15. Intranasal Delivery of Apelin-13 Is Neuroprotective and Promotes Angiogenesis After Ischemic Stroke in Mice.
Chen D; Lee J; Gu X; Wei L; Yu SP
ASN Neuro; 2015; 7(5):. PubMed ID: 26391329
[TBL] [Abstract][Full Text] [Related]
16. Neuroprotection after cerebral ischemia.
Namura S; Ooboshi H; Liu J; Yenari MA
Ann N Y Acad Sci; 2013 Mar; 1278():25-32. PubMed ID: 23488559
[TBL] [Abstract][Full Text] [Related]
17. Target brain: neuroprotection and neurorestoration in ischemic stroke.
Saver JL
Rev Neurol Dis; 2010; 7 Suppl 1():S14-21. PubMed ID: 20410866
[TBL] [Abstract][Full Text] [Related]
18. Translation of ischemic preconditioning to the patient: prolyl hydroxylase inhibition and hypoxia inducible factor-1 as novel targets for stroke therapy.
Ratan RR; Siddiq A; Aminova L; Lange PS; Langley B; Ayoub I; Gensert J; Chavez J
Stroke; 2004 Nov; 35(11 Suppl 1):2687-9. PubMed ID: 15472113
[TBL] [Abstract][Full Text] [Related]
19. Improving outcome after stroke: overcoming the translational roadblock.
Endres M; Engelhardt B; Koistinaho J; Lindvall O; Meairs S; Mohr JP; Planas A; Rothwell N; Schwaninger M; Schwab ME; Vivien D; Wieloch T; Dirnagl U
Cerebrovasc Dis; 2008; 25(3):268-78. PubMed ID: 18292653
[TBL] [Abstract][Full Text] [Related]
20. The role of diffusion- and perfusion-weighted magnetic resonance imaging in drug development for ischemic stroke: from laboratory to clinics.
Tatlisumak T; Strbian D; Abo Ramadan U; Li F
Curr Vasc Pharmacol; 2004 Oct; 2(4):343-55. PubMed ID: 15320814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
